Virios Therapeutics CEO Greg Duncan receives $3.5M in 2020
Virios Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 26, 2022
Virios Therapeutics reported fiscal year 2020 executive compensation information on April 26, 2022.
In 2020, six executives at Virios Therapeutics received on average a compensation package of $1.6M, a 357% increase compared to previous year.
Average pay of disclosed executives at Virios Therapeutics
Greg Duncan, Chief Executive Officer, received $3.5M in total. 82% of Duncan's compensation, or $2.9M, was in option awards. Duncan also received $250K in non-equity incentive plan, $375K in salary, as well as $27K in other compensation.
Richard Burch, President, received a compensation package of $2.7M, which increased by 659% compared to previous year. 75% of the compensation package, or $2M, was in option awards.
William L. Pridgen, Chief Executive Officer, earned $2.4M in 2020, a 593% increase compared to previous year.
Angela Walsh, Vice President of Finance, received $481K in 2020.
Ralph Grosswald, Vice President of Operations, earned $461K in 2020.
R. Michael Gendreau, Chief Medical Officer, received $30K in 2020.
Related executives
R Gendreau
Virios Therapeutics
Chief Medical Officer
William Pridgen
Virios Therapeutics
Chief Executive Officer
Richard Burch
Virios Therapeutics
President
Greg Duncan
Virios Therapeutics
Chief Executive Officer
Angela Walsh
Virios Therapeutics
Senior Vice President of Finance
Ralph Grosswald
Virios Therapeutics
Vice President of Operations
You may also like
Source: SEC filing on April 26, 2022.